SA-ODG platform: a semi-automated and PCR-free method to analyse microRNAs in solid tissues.


Journal

The Analyst
ISSN: 1364-5528
Titre abrégé: Analyst
Pays: England
ID NLM: 0372652

Informations de publication

Date de publication:
12 Jul 2024
Historique:
medline: 12 7 2024
pubmed: 12 7 2024
entrez: 12 7 2024
Statut: aheadofprint

Résumé

Over the past two decades, numerous techniques have been developed for analysing microRNAs in body fluids and tissues. However, these techniques still face technical challenges, particularly when compared to well-established techniques for proteins and metabolites. Recently, the ODG platform was introduced, which is an innovative technology that allows for the direct detection and quantification of microRNAs in liquid biopsies without requiring extraction or amplification. This study presents the implementation of the ODG platform within a semi-automated protocol to create the "SA-ODG" platform, enhancing the efficiency and precision of microRNA testing while reducing hands-on time required by laboratory staff. For the first time, the SA-ODG platform has been used to directly quantify microRNAs in solid tissues. The results demonstrate precise analysis of miR-122-5p in mouse liver tissues using SA-ODG. These developments represent a crucial step forward in advancing the field of extraction and amplification-free microRNA detection and quantification.

Identifiants

pubmed: 38994789
doi: 10.1039/d4an00783b
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

S Detassis (S)

OPTOI SRL, Via Vienna 8, 38121, Trento, Italy. salvatore.pernagallo@destinagenomics.com.

F Precazzini (F)

Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Via Sommarive 9, 38123, Trento, Italy.

I Brentari (I)

Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Via Sommarive 9, 38123, Trento, Italy.

R Ruffilli (R)

OPTOI SRL, Via Vienna 8, 38121, Trento, Italy. salvatore.pernagallo@destinagenomics.com.

C Ress (C)

OPTOI SRL, Via Vienna 8, 38121, Trento, Italy. salvatore.pernagallo@destinagenomics.com.

A Maglione (A)

OPTOI SRL, Via Vienna 8, 38121, Trento, Italy. salvatore.pernagallo@destinagenomics.com.

S Pernagallo (S)

DESTINA Genomica SL, Parque Tecnológico de la Salud (PTS), Avenida de la Innovación 1, 18016 Granada, Spain.

M A Denti (MA)

Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Via Sommarive 9, 38123, Trento, Italy.

Classifications MeSH